Chairman & CEO of Betta Pharmaceuticals (2003-now)

National High-level Talent Program Expert, National “New Drug Innovation” committee member, recipient of the State Council’s allowance. Doctor of Medicine (M.D.) from the University of Arkansas (U.S.), U.S.-certified pathologist. The 12th and 13th National People's Congress member, Standing Committee member and the Deputy Director of the Special Committee on Biological and Medical Special Committees of China Federation of Returned Overseas Chinese, Vice Chairman of Zhejiang Overseas Chinese Federation, Director of the Central Economic and Financial Committee of Chinese Peasants And Workers Democratic Party, Deputy Chairman of the Zhejiang Provincial Committee, Vice President of China Pharmaceutical Innovation and Research Development Association, President of Zhejiang Pharmaceutical Industry Association. In 2003, Dr. Ding founded Betta Pharmaceuticals Co., Ltd., and led the team to successfully develop China's first small-molecule anti-cancer targeted therapy——icotinib, building a leading R&D and commercialization platform for anti-cancer targeted therapies. He has presided 13 national-level major science and technology projects such as the “New Drug Innovation”, applied for 84 patents, and published 29 articles. Because of his outstanding contributions, Dr. Ding has won National Science and Technology Progress Award (the first accomplisher), Gold Prize of China Patent Award, National Innovation Award, China Industrial Award, National Outstanding Professional and Technical Personnel, National Outstanding Science and Technology Workers, "Top 10" of Overseas Chinese, Zhejiang Province Science and Technology Major Contribution Award and other honors.

20 years’ biopharma experience

Chairman & CEO of Mab-works (2011-now)

Expertise in media development process development and manufacturing

VP & CFO of Betta Pharmaceuticals (2016-now)

He has served as the president of China Construction Bank Yuhang branch, China Construction Bank Xiaoshan branch, and Shanghai Pudong Development Bank Yuhang branch. With more than 20 years of operation and management experiences in the financial industry, he has amassed strong communication, coordination, and team management skills. Mr. Fan is in charge of the finance and investment departments.

20 years’ biopharma experience

Former CMC SVP at I-Mab and Akeso，GM of Generon Beijing

Contributed to >50 biologics Dev., MFG and global filings in US and China

Oversaw CMC activities for the 1st China’s innovative biologics entering Phase II & III clinical trials  and commercialization process

30 years’ biopharma experience

VP of Mab-works (2012-2022)

Expertise in cell line development, process development and manufacturing